» Articles » PMID: 14724673

Hydroporation As the Mechanism of Hydrodynamic Delivery

Overview
Journal Gene Ther
Date 2004 Jan 16
PMID 14724673
Citations 104
Authors
Affiliations
Soon will be listed here.
Abstract

We have reported that a rapid tail vein injection of a large volume of plasmid DNA solution into a mouse results in high level of transgene expression in the liver. Gene transfer efficiency of this hydrodynamics-based procedure is determined by the combined effect of a large volume and high injection speed. Here, we show that the hydrodynamic injection induces a transient irregularity of heart function, a sharp increase in venous pressure, an enlargement of liver fenestrae, and enhancement of membrane permeability of the hepatocytes. At the cellular level, our results suggest that hepatic delivery by the hydrodynamic injection is accomplished by the generation of membrane pores in the hepatocytes.

Citing Articles

Gene targeting in adult organs using in vivo cleavable donor plasmids for CRISPR-Cas9 and CRISPR-Cas12a.

Ishibashi R, Maki R, Toyoshima F Sci Rep. 2024; 14(1):7615.

PMID: 38556532 PMC: 10982285. DOI: 10.1038/s41598-024-57551-8.


Oncogene-Driven Induction of Orthotopic Cholangiocarcinoma in Mice.

Plantureux C, Paillet J, Autret G, Perez-Lanzon M, Kroemer G, Maiuri M Methods Mol Biol. 2024; 2769:99-108.

PMID: 38315392 DOI: 10.1007/978-1-0716-3694-7_8.


Current State of Human Gene Therapy: Approved Products and Vectors.

Shchaslyvyi A, Antonenko S, Tesliuk M, Telegeev G Pharmaceuticals (Basel). 2023; 16(10).

PMID: 37895887 PMC: 10609992. DOI: 10.3390/ph16101416.


Hydrodynamic Delivery: Characteristics, Applications, and Technological Advances.

Suda T, Yokoo T, Kanefuji T, Kamimura K, Zhang G, Liu D Pharmaceutics. 2023; 15(4).

PMID: 37111597 PMC: 10141091. DOI: 10.3390/pharmaceutics15041111.


Prolonged activity of the transposase helper may raise safety concerns during DNA transposon-based gene therapy.

Imre G, Takacs B, Czipa E, Drubi A, Jaksa G, Latinovics D Mol Ther Methods Clin Dev. 2023; 29:145-159.

PMID: 37025950 PMC: 10070360. DOI: 10.1016/j.omtm.2023.03.003.


References
1.
Kobayashi N, Kuramoto T, Yamaoka K, Hashida M, Takakura Y . Hepatic uptake and gene expression mechanisms following intravenous administration of plasmid DNA by conventional and hydrodynamics-based procedures. J Pharmacol Exp Ther. 2001; 297(3):853-60. View

2.
Zabner J, Fasbender A, Moninger T, Poellinger K, Welsh M . Cellular and molecular barriers to gene transfer by a cationic lipid. J Biol Chem. 1995; 270(32):18997-9007. DOI: 10.1074/jbc.270.32.18997. View

3.
Yant S, Meuse L, Chiu W, Ivics Z, Izsvak Z, Kay M . Somatic integration and long-term transgene expression in normal and haemophilic mice using a DNA transposon system. Nat Genet. 2000; 25(1):35-41. DOI: 10.1038/75568. View

4.
Kramer M, Barajas M, Razquin N, Berraondo P, Rodrigo M, Wu C . In vitro and in vivo comparative study of chimeric liver-specific promoters. Mol Ther. 2003; 7(3):375-85. DOI: 10.1016/s1525-0016(02)00060-6. View

5.
Song E, Lee S, Wang J, Ince N, Ouyang N, Min J . RNA interference targeting Fas protects mice from fulminant hepatitis. Nat Med. 2003; 9(3):347-51. DOI: 10.1038/nm828. View